Mahamaya Lifesciences Limited (BOM:544611)

Mahamaya Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	393.99	39.95	30.15	30.44	13.65
Cash & Short-Term Investments	393.99	39.95	30.15	30.44	13.65
Cash Growth	886.23%	32.52%	-0.98%	122.99%	-
Accounts Receivable	707.6	484.63	283.09	95.28	91.06
Other Receivables	48.12	2.21	0.89	0.58	0.16
Receivables	755.72	486.83	283.98	95.86	91.23
Inventory	1,424	1,006	516.37	369.52	191.76
Prepaid Expenses	3.11	1.95	0.92	0.6	0.64
Other Current Assets	88.01	32.77	41.76	43.59	35.96
Total Current Assets	2,664	1,567	873.18	540.01	333.24
Property, Plant & Equipment	288.27	217.4	183.26	177.76	170.58
Other Intangible Assets	25.97	41.21	29.56	35.3	40.62
Long-Term Deferred Tax Assets	-	-	-	-	1.05
Long-Term Deferred Charges	119.71	53.12	31.68	22.48	8.32
Other Long-Term Assets	4.41	4.49	3.3	3.29	3.34
Total Assets	3,103	1,884	1,121	778.83	557.13

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	644.41	550.68	226.58	276.45	165.56
Accrued Expenses	227.2	182.88	41.56	12.7	15.36
Short-Term Debt	842.93	488.34	433.43	115.56	78.73
Current Portion of Long-Term Debt	28.76	31.2	27.35	25.16	16.13
Current Income Taxes Payable	41.85	33.57	14.8	9.34	9.21
Other Current Liabilities	46.19	29.6	36.25	37.43	15.17
Total Current Liabilities	1,831	1,316	779.97	476.64	300.16
Long-Term Debt	35.68	61.6	85.48	103	96.79
Pension & Post-Retirement Benefits	3.61	3.29	2.72	2.27	2.46
Long-Term Deferred Tax Liabilities	12.05	7.07	4.14	1.73	-
Other Long-Term Liabilities	0.82	1.1	0.81	0.8	0.65
Total Liabilities	1,884	1,389	873.11	584.44	400.06

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	234.05	177.66	12.49	12.49	12.49
Additional Paid-In Capital	604.32	100.31	-	-	-
Retained Earnings	381.76	216.53	235.24	181.78	144.27
Comprehensive Income & Other	-0.83	-0.3	0.14	0.13	0.31
Shareholders' Equity	1,219	494.2	247.86	194.4	157.06
Total Liabilities & Equity	3,103	1,884	1,121	778.83	557.13

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	907.37	581.14	546.26	243.73	191.65
Net Cash (Debt)	-513.38	-541.19	-516.11	-213.28	-178
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-25.88	-31.76	-37.57	-15.53	-12.96
Filing Date Shares Outstanding	23.41	17.77	13.74	13.74	13.74
Total Common Shares Outstanding	23.41	17.77	13.74	13.74	13.74
Working Capital	833.12	251.04	93.21	63.37	33.08
Book Value Per Share	52.10	27.82	18.04	14.15	11.43
Tangible Book Value	1,193	452.99	218.3	159.09	116.44
Tangible Book Value Per Share	50.99	25.50	15.89	11.58	8.48
Land	38.54	38.54	41.04	41.04	41.04
Buildings	125.87	111.3	98.38	97.58	94.14
Machinery	124.34	112.08	81.88	71.05	59.48
Construction In Progress	57.44	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 22, 2026

Data Sources Report a data error